Introductory Clinical Pharmacology Test Bank for Roa
b b b b b b
ch's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
1. Abnursingbinstructorbisbpreparingbabteachingbplanbforbabgroupbofbnursingbstudentsbaboutbph
armacology.bWhenbdescribingbthisbtopic,bthebinstructorbwouldbfocusbthebdiscussionbonbwhi
chbofbthebfollowingbasbanbessentialbaspect?
A) Drugbname
B) Drugbclass
C) Drugbaction
D) Drugbsourceb
Ans:b CbFeedbac
k:
Pharmacologybisbthebstudybofbdrugsbandbtheirbactionbonblivingborganisms.bThus,banbessenti
albaspectbofbpharmacologybisbdrugbaction.bAnbunderstandingbofbthebdrugbname,bdrugbclass,ba
ndbdrugbsourcebisbimportant,bbutbthebmostbcriticalbaspectbrelatedbtobpharmacologybisbhowbth
ebdrugbactsbinbthebbody.
2. Abnursingbstudentbisbpreparingbtobadministerbabprescribedbdrugbtobabpatient.bThebstudentbre
viewsbinformationbaboutbthebdrugbandbitsbactions.bWhichbofbthebfollowingbwouldbbebthebbes
tbchoicebforbobtainingbthisbinformation?bSelectballbthatbapply.
A) Nursingbinstructor
B) Nursebassignedbtobthebpatient
C) Clinicalbdrugbreference
D) Prescribingbhealthbcarebprovider
E) Clinicalbpharmacistb
Ans:b C,bE
Feedback:
Althoughbthebnursingbstudentbcanbaskbthebnursingbinstructor,bthebnursebassignedbtobthebpati
ent,bandbthebprescribingbhealthbcarebproviderbforbinformationbaboutbthebdrug,bthebbestbchoic
esbforbdrugbinformationbwouldbincludebanbappropriatebdrugbreferencebandbthebclinicalbphar
macist.
3. Whenbdescribingbthebvariousbtypesbofbmedicationsbtobabgroupbofbnursingbstudents,babn
ursingbinstructorbwouldbidentifybwhichbofbthebfollowingbasbabsourcebforbderivingbme
dications?bSelectballbthatb apply.
A) Plants
B) Syntheticbsources
C) Mold
D) Minerals
E) AnimalsbAn
s:bA,bB,bC,bD,bEbFe
edback:
Medicationsbarebderivedbfrombnaturalbsources,bforbexample,bplants,bmolds,bminerals,bandban
imals,basbwellbasbcreatedbsyntheticallybinbablaboratory.
Pageb 1
,Introductory Clinical Pharmacology Test Bank for Ro
b b b b b b
ach's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
4. Whichbofbthebfollowingbnamesbmaybbebassignedbtobabdrugbduringbthebprocessbofbd
evelopment?bSelectballbthatbapply.
A) Chemicalbname
B) Officialbname
C) Pharmacologicbname
D) Tradebname
E) Nonproprietarybnameb
Ans:b A,bB,bD,bEbFeedback
:
Throughoutbthebprocessbofbdevelopment,bdrugsbmaybhavebseveralbnamesbassignedbtobthem
bincludingbabchemical bname,babgenericb(nonproprietary)bname,banbofficialbname,bandbabtrade
borbbrandb name.
5. Abdrugbmaybbebclassifiedbbybwhichbofbthebfollowing?bSelectballbthatbapply.
A) Thebchemicalbtypebofbthebdrug'sbactivebingredient
B) Thebwaybthebdrugbisbusedbtobtreatbabspecificbcondition
C) Thebgenericbnamebofbthebdrug
D) Thebtradebnamebofbthebdrug
E) Thebnonproprietarybnamebofbthebdrugb
Ans:b A,bB
Feedback:
Abdrugbmaybbebclassifiedbbybthebchemicalbtypebofbthebactivebingredientborbbybthebwaybitb isbu
sedbtobtreatbabparticularbcondition.bGeneric,btrade,bandbnonproprietarybreferbtobhowbabdrugbi
sbnamed.
6. Abgroupbofbnursingbstudentsbarebreviewingbinformationbaboutbthebprocessbofbdrugbdeve
lopmentbinbthebUnitedbStates.bThebstudentsbdemonstratebunderstandingbofbthisbprocessb
whenbtheybidentifybthatbwhichbofbthebfollowingbcategoriesbarebassignedbbybthebFoodband
bDrugbAdministrationbtobnewlybapprovedbdrugs? bSelectb all bthatbapply.
A) Metabolite
B) Noncontrolledbsubstance
C) Prescription
D) Nonprescription
E) Controlledbsubstanceb
Ans:b C,bD,bE
Feedback:
Oncebdrugsbarebapprovedbforbuse,bthebFDAbassignsbthebdrugbtobonebofbthebfollowingbcateg
ories:bprescription,bnonprescription,borbcontrolledbsubstance.bMetabolitebrefersbtobthebinact
ivebformbofbthebdrug.bNoncontrolledbsubstancebisbabtermbthatbisbnotbused.
Pageb 2
,Introductory Clinical Pharmacology Test Bank for Ro
b b b b b b
ach's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
7. hichbofbthebfollowingbwouldbbebmostbimportantbforbthebnursebtobdobtobensurebthebsafebu
sebofbprescriptionbdrugsbinbthebinstitutionalbsetting?bSelectballbthatbapply.
A) Administeringbdrugs
B) Monitoringbclientsbforbdrugbeffects
C) Prescribingbdrugs
D) Evaluatingbclientsbforbtoxicbeffects
E) Educatingbclients/caregiversbaboutbdrugsb
Ans:b A,bB,bD,bE
Feedback:
Inbthebinstitutionalbsetting,bthebnurse'sbrolebtobensurebsafebusebofbprescriptionbdrugsbinclude
sbadministeringbdrugs,bmonitoringbdrugbeffects,bevaluatingbforbtoxicbeffects,bandbeducatingb
clientsbandbcaregiversbaboutbdrugs.
8. Thebnursebisbhelpingbabclientbreviewbabprescriptionbfrombthebhealthbcarebprovider.bWhenbe
xaminingbthebprescription,bwhichbofbthebfollowingbwouldbthebnursebexpectbtobfindbdocu
mented?bSelectballbthatbapply.
A) Namebofbthebdrug
B) Dosagebofbthebdrug
C) Routebofbdrugbadministration
D) Timesbofbdrugbadministration
E) Licensedbprescriber'sbsignatureb
Ans:b A,bB,bC,bD,bE
Feedback:
Thebprescriptionbmustbcontainbthebclient'sbname,bthebnamebofbthebdrug,bthebdosage,bthebmet
hodbandbtimesbofbadministration,bandbthebsignaturebofbtheblicensedbhealthbcarebproviderbpr
escribingbthebdrug.
9. Afterbteachingbabgroupbofbnursingbstudentsbaboutbnonprescriptionbdrugs,bthebnursingbinstr
uctorbdeterminesbthatbthebteachingbwasbsuccessfulbwhenbthebstudentsbidentifybwhichbofbthe
bfollowing? bSelectb all bthatb apply.
A) Theybrequirebablicensedbhealthbcarebprovider'sbsignature.
B) Theybarebreferredbtobasbover-the-counterbdrugs.
C) Theybcanbbebtakenbwithoutbriskbtobthebclient.
D) Theybhavebcertainblabelingbrequirements.
E) Theybshouldbbebtakenbonlybasbdirectedbonbtheblabel.b
Ans:b B,bD,bE
Feedback:
Nonprescriptionbdrugsbareboftenbreferredbtobasbover-the-
counterb(OTC)bdrugs.bTheybdobnotbrequirebabprescriptionb(ablicensedbhealthbcarebprovider'
sbsignature)bbutbdobnotbcomebwithoutbriskbtobthebclient.bThebfederalbgovernmentbhasbimpos
edblabelingbrequirementsbofbOTCbdrugsbandbtheybshouldbonlybbebtakenbasbdirectedbonbthebl
abelbunlessbunderbthebsupervisionbofbabhealthbcarebprovider.
Pageb 3
, Introductory Clinical Pharmacology Test Bank for Ro
b b b b b b
ach's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
10. AbnursingbstudentbisbreviewingbinformationbaboutbthebControlledbSubstancesbActbofb19
70.bThebstudentbwouldbexpectbtobfindbwhichbofbthebfollowingbasbbeingbregulatedbforbdru
gsbclassifiedbasbcontrolledbsubstances?bSelectb allbthatbapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensingb
Ans:b A,bC,bEbFee
dback:
ThebControlledbSubstancesbActbofb1970bregulatesbthebmanufacture,bdistribution,bandbdispe
nsingbofbdrugsbclassifiedbasbcontrolledbsubstances.bEliminationbrefersbtobthebexcretionbofbd
rugsbfrombthebbody,babpharmacokineticbactivity.bThebactbdoesbnotbaddressbformulationbofbth
ebdrug.
11. WhenbreviewingbinformationbaboutbthebOrphanbDrugbProgram,bwhichbofbthebfollowingb
wouldbthebnursebexpectbtobfind?bSelectballbthatb apply.
A) Thebprogrambencouragesbthebdevelopmentb andbmarketingbofbproductsbtobtreatbrarebd
iseases.
B) Thebprogrambgrantsbprovisionalbapprovalbwithbabwrittenbcommitmentbfrombthebd
rugbcompanybtobformallybdemonstratebclientbbenefits.
C) Thebprogrambprovidesbforbincentives,bsuchbasbresearchbgrants,bprotocolbassistance,ba
ndbspecialbtaxbcredits,btob developbproductsbtobtreatbrarebdiseases.
D) Thebprogrambgrantsb7byearsbofbexclusivebmarketingbrightsbtobthebmanufacturerbifba
pproved.
E) Thebprogrambacceleratesbapprovalbofbdrugsbbasedbonbpreliminarybevidencebbeforebf
ormalbdemonstrationbofbclientbbenefits.
Ans:b A,bC,bD
Feedback:
ThebOrphanbDrugbProgrambencouragesbthebdevelopmentbandbmarketingbofbproductsbusedbt
obtreatbrarebdiseases.bThebprogrambprovidesbincentivesbtobencouragebmanufacturersbtobdev
elopborphanbdrugs,bandbifbapproved,bthebmanufacturerbhasb7byearsbofbexclusivebmarketingb
rights.bAcceleratedbprogramsbinvolvebprovisionalbapprovalbandbapprovalbbasedbonbprelimi
narybevidence.
Pageb 4
b b b b b b
ch's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
1. Abnursingbinstructorbisbpreparingbabteachingbplanbforbabgroupbofbnursingbstudentsbaboutbph
armacology.bWhenbdescribingbthisbtopic,bthebinstructorbwouldbfocusbthebdiscussionbonbwhi
chbofbthebfollowingbasbanbessentialbaspect?
A) Drugbname
B) Drugbclass
C) Drugbaction
D) Drugbsourceb
Ans:b CbFeedbac
k:
Pharmacologybisbthebstudybofbdrugsbandbtheirbactionbonblivingborganisms.bThus,banbessenti
albaspectbofbpharmacologybisbdrugbaction.bAnbunderstandingbofbthebdrugbname,bdrugbclass,ba
ndbdrugbsourcebisbimportant,bbutbthebmostbcriticalbaspectbrelatedbtobpharmacologybisbhowbth
ebdrugbactsbinbthebbody.
2. Abnursingbstudentbisbpreparingbtobadministerbabprescribedbdrugbtobabpatient.bThebstudentbre
viewsbinformationbaboutbthebdrugbandbitsbactions.bWhichbofbthebfollowingbwouldbbebthebbes
tbchoicebforbobtainingbthisbinformation?bSelectballbthatbapply.
A) Nursingbinstructor
B) Nursebassignedbtobthebpatient
C) Clinicalbdrugbreference
D) Prescribingbhealthbcarebprovider
E) Clinicalbpharmacistb
Ans:b C,bE
Feedback:
Althoughbthebnursingbstudentbcanbaskbthebnursingbinstructor,bthebnursebassignedbtobthebpati
ent,bandbthebprescribingbhealthbcarebproviderbforbinformationbaboutbthebdrug,bthebbestbchoic
esbforbdrugbinformationbwouldbincludebanbappropriatebdrugbreferencebandbthebclinicalbphar
macist.
3. Whenbdescribingbthebvariousbtypesbofbmedicationsbtobabgroupbofbnursingbstudents,babn
ursingbinstructorbwouldbidentifybwhichbofbthebfollowingbasbabsourcebforbderivingbme
dications?bSelectballbthatb apply.
A) Plants
B) Syntheticbsources
C) Mold
D) Minerals
E) AnimalsbAn
s:bA,bB,bC,bD,bEbFe
edback:
Medicationsbarebderivedbfrombnaturalbsources,bforbexample,bplants,bmolds,bminerals,bandban
imals,basbwellbasbcreatedbsyntheticallybinbablaboratory.
Pageb 1
,Introductory Clinical Pharmacology Test Bank for Ro
b b b b b b
ach's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
4. Whichbofbthebfollowingbnamesbmaybbebassignedbtobabdrugbduringbthebprocessbofbd
evelopment?bSelectballbthatbapply.
A) Chemicalbname
B) Officialbname
C) Pharmacologicbname
D) Tradebname
E) Nonproprietarybnameb
Ans:b A,bB,bD,bEbFeedback
:
Throughoutbthebprocessbofbdevelopment,bdrugsbmaybhavebseveralbnamesbassignedbtobthem
bincludingbabchemical bname,babgenericb(nonproprietary)bname,banbofficialbname,bandbabtrade
borbbrandb name.
5. Abdrugbmaybbebclassifiedbbybwhichbofbthebfollowing?bSelectballbthatbapply.
A) Thebchemicalbtypebofbthebdrug'sbactivebingredient
B) Thebwaybthebdrugbisbusedbtobtreatbabspecificbcondition
C) Thebgenericbnamebofbthebdrug
D) Thebtradebnamebofbthebdrug
E) Thebnonproprietarybnamebofbthebdrugb
Ans:b A,bB
Feedback:
Abdrugbmaybbebclassifiedbbybthebchemicalbtypebofbthebactivebingredientborbbybthebwaybitb isbu
sedbtobtreatbabparticularbcondition.bGeneric,btrade,bandbnonproprietarybreferbtobhowbabdrugbi
sbnamed.
6. Abgroupbofbnursingbstudentsbarebreviewingbinformationbaboutbthebprocessbofbdrugbdeve
lopmentbinbthebUnitedbStates.bThebstudentsbdemonstratebunderstandingbofbthisbprocessb
whenbtheybidentifybthatbwhichbofbthebfollowingbcategoriesbarebassignedbbybthebFoodband
bDrugbAdministrationbtobnewlybapprovedbdrugs? bSelectb all bthatbapply.
A) Metabolite
B) Noncontrolledbsubstance
C) Prescription
D) Nonprescription
E) Controlledbsubstanceb
Ans:b C,bD,bE
Feedback:
Oncebdrugsbarebapprovedbforbuse,bthebFDAbassignsbthebdrugbtobonebofbthebfollowingbcateg
ories:bprescription,bnonprescription,borbcontrolledbsubstance.bMetabolitebrefersbtobthebinact
ivebformbofbthebdrug.bNoncontrolledbsubstancebisbabtermbthatbisbnotbused.
Pageb 2
,Introductory Clinical Pharmacology Test Bank for Ro
b b b b b b
ach's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
7. hichbofbthebfollowingbwouldbbebmostbimportantbforbthebnursebtobdobtobensurebthebsafebu
sebofbprescriptionbdrugsbinbthebinstitutionalbsetting?bSelectballbthatbapply.
A) Administeringbdrugs
B) Monitoringbclientsbforbdrugbeffects
C) Prescribingbdrugs
D) Evaluatingbclientsbforbtoxicbeffects
E) Educatingbclients/caregiversbaboutbdrugsb
Ans:b A,bB,bD,bE
Feedback:
Inbthebinstitutionalbsetting,bthebnurse'sbrolebtobensurebsafebusebofbprescriptionbdrugsbinclude
sbadministeringbdrugs,bmonitoringbdrugbeffects,bevaluatingbforbtoxicbeffects,bandbeducatingb
clientsbandbcaregiversbaboutbdrugs.
8. Thebnursebisbhelpingbabclientbreviewbabprescriptionbfrombthebhealthbcarebprovider.bWhenbe
xaminingbthebprescription,bwhichbofbthebfollowingbwouldbthebnursebexpectbtobfindbdocu
mented?bSelectballbthatbapply.
A) Namebofbthebdrug
B) Dosagebofbthebdrug
C) Routebofbdrugbadministration
D) Timesbofbdrugbadministration
E) Licensedbprescriber'sbsignatureb
Ans:b A,bB,bC,bD,bE
Feedback:
Thebprescriptionbmustbcontainbthebclient'sbname,bthebnamebofbthebdrug,bthebdosage,bthebmet
hodbandbtimesbofbadministration,bandbthebsignaturebofbtheblicensedbhealthbcarebproviderbpr
escribingbthebdrug.
9. Afterbteachingbabgroupbofbnursingbstudentsbaboutbnonprescriptionbdrugs,bthebnursingbinstr
uctorbdeterminesbthatbthebteachingbwasbsuccessfulbwhenbthebstudentsbidentifybwhichbofbthe
bfollowing? bSelectb all bthatb apply.
A) Theybrequirebablicensedbhealthbcarebprovider'sbsignature.
B) Theybarebreferredbtobasbover-the-counterbdrugs.
C) Theybcanbbebtakenbwithoutbriskbtobthebclient.
D) Theybhavebcertainblabelingbrequirements.
E) Theybshouldbbebtakenbonlybasbdirectedbonbtheblabel.b
Ans:b B,bD,bE
Feedback:
Nonprescriptionbdrugsbareboftenbreferredbtobasbover-the-
counterb(OTC)bdrugs.bTheybdobnotbrequirebabprescriptionb(ablicensedbhealthbcarebprovider'
sbsignature)bbutbdobnotbcomebwithoutbriskbtobthebclient.bThebfederalbgovernmentbhasbimpos
edblabelingbrequirementsbofbOTCbdrugsbandbtheybshouldbonlybbebtakenbasbdirectedbonbthebl
abelbunlessbunderbthebsupervisionbofbabhealthbcarebprovider.
Pageb 3
, Introductory Clinical Pharmacology Test Bank for Ro
b b b b b b
ach's By Ford MN RN CNE, Susan M TEST BANK
b b b b b b b b b
With Rationale
b
10. AbnursingbstudentbisbreviewingbinformationbaboutbthebControlledbSubstancesbActbofb19
70.bThebstudentbwouldbexpectbtobfindbwhichbofbthebfollowingbasbbeingbregulatedbforbdru
gsbclassifiedbasbcontrolledbsubstances?bSelectb allbthatbapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensingb
Ans:b A,bC,bEbFee
dback:
ThebControlledbSubstancesbActbofb1970bregulatesbthebmanufacture,bdistribution,bandbdispe
nsingbofbdrugsbclassifiedbasbcontrolledbsubstances.bEliminationbrefersbtobthebexcretionbofbd
rugsbfrombthebbody,babpharmacokineticbactivity.bThebactbdoesbnotbaddressbformulationbofbth
ebdrug.
11. WhenbreviewingbinformationbaboutbthebOrphanbDrugbProgram,bwhichbofbthebfollowingb
wouldbthebnursebexpectbtobfind?bSelectballbthatb apply.
A) Thebprogrambencouragesbthebdevelopmentb andbmarketingbofbproductsbtobtreatbrarebd
iseases.
B) Thebprogrambgrantsbprovisionalbapprovalbwithbabwrittenbcommitmentbfrombthebd
rugbcompanybtobformallybdemonstratebclientbbenefits.
C) Thebprogrambprovidesbforbincentives,bsuchbasbresearchbgrants,bprotocolbassistance,ba
ndbspecialbtaxbcredits,btob developbproductsbtobtreatbrarebdiseases.
D) Thebprogrambgrantsb7byearsbofbexclusivebmarketingbrightsbtobthebmanufacturerbifba
pproved.
E) Thebprogrambacceleratesbapprovalbofbdrugsbbasedbonbpreliminarybevidencebbeforebf
ormalbdemonstrationbofbclientbbenefits.
Ans:b A,bC,bD
Feedback:
ThebOrphanbDrugbProgrambencouragesbthebdevelopmentbandbmarketingbofbproductsbusedbt
obtreatbrarebdiseases.bThebprogrambprovidesbincentivesbtobencouragebmanufacturersbtobdev
elopborphanbdrugs,bandbifbapproved,bthebmanufacturerbhasb7byearsbofbexclusivebmarketingb
rights.bAcceleratedbprogramsbinvolvebprovisionalbapprovalbandbapprovalbbasedbonbprelimi
narybevidence.
Pageb 4
